UK banks on COVID-19 antivirals for winter

By Clara-Laeila Laudette
Updated December 17 2021 - 5:56am, first published 5:49am
UK tests are trialling Merck's molnupiravir pill in COVID-19 patients at risk of serious illness.
UK tests are trialling Merck's molnupiravir pill in COVID-19 patients at risk of serious illness.

The United Kingdom expects to have antiviral COVID-19 pills produced by Merck and Pfizer available over the northern hemisphere winter, its Antiviral Taskforce Chair says as Omicron continues its lightning advance through the country.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Wagga Wagga news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.